ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

LXRX Lexicon Pharmaceuticals Inc

1.865
0.075 (4.19%)
Last Updated: 19:40:55
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 37k35k39k28k24k316k162k702k
Operating Income -23.38M-24.01M-23.1M-30.28M-31.14M-44.24M-49.63M-46.74M
Pre Tax Income -23.48M-24.59M-23.39M-30.49M-31.93M-44.9M-50.53M-49.76M
Net Income -23.48M-24.59M-23.39M-30.49M-31.93M-44.9M-50.53M-49.76M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -23.38M-24.01M-23.1M-30.28M-31.14M-44.24M-49.63M-46.74M
EBITDA -23.27M-23.9M-22.99M-30.18M-31.03M-44.1M-49.48M-46.59M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 84.04M90.34M63.21M322.07M24M298k139k1.2M
Operating Income -137.16M-136.68M-103.28M141.45M-180.39M-87.09M-100.76M-171.75M
Pre Tax Income -141.43M-141.71M-120.55M124.12M-58.57M-87.76M-101.94M-177.12M
Net Income -141.43M-129.05M-120.55M130.13M-58.57M-87.76M-101.94M-177.12M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.356-1.222-1.1381.225-0.414-0.589-0.54-0.723
EBIT -137.16M-136.68M-103.28M141.45M-46.8M-87.09M-100.76M-171.75M
EBITDA -135.1M-133.28M-99.6M173.74M-175.85M-86.8M-100.33M-171.2M

Your Recent History

Delayed Upgrade Clock